Editorial Board About Us

J Curtis Nickel

All articles from this author are listed below.

Volume 8, Number 3 Literature Reviews

Interstitial Cystitis

Reviewing the Literature

J Curtis Nickel

Volume 8, Number 1 Meeting Reviews

Changing Paradigms for Chronic Pelvic Pain

Meeting Review

Michel Pontari Richard Berger J Curtis Nickel

A Report from the Chronic Pelvic Pain/Chronic Prostatitis Scientific Workshop October 19-21, 2005 Baltimore, MD

Interstitial cystitis Chronic pelvic pain syndrome Prostatitis Pain Psychosocial aspects of pain Alternative treatments Biopsychosocial treatment model

Volume 9, Number 3 Meeting Reviews

Best of the 2007 AUA Annual Meeting

Meeting Review

Jacob Rajfer Claus G Roehrborn Michael K Brawer Dean G Assimos Danil V Makarov Ellen Shapiro Alan W Partin Michael B Chancellor J Curtis Nickel

Highlights from the 2007 Annual Meeting of the American Urological Association May 19-24, 2007 Anaheim, CA [Rev Urol. 2007;9(3):133-154]

Prostate cancer Obesity Benign prostatic hyperplasia Antibiotic prophylaxis Nocturia Lower urinary tract symptoms Botulinum toxin Prostate-specific antigen Biomarkers PCA3 Testosterone Urinary tract infections Urolithiasis Laser ablation Endourology Male voiding dysfunction LHRH antagonists Antimuscarinic agents Circumcision Repeat biopsy Human glandularkallikrein Expectant management CRISP-3 MSP Microvesseldensity Endoglin Survivin Telomeres Interleukin-8 PDE-5 inhibitors Acute urinaryretention 5Alpha-reductase inhibitors Doxazosin Finasteride Transurethral microwave thermotherapy TURP Perioperative blood loss Microbialbiofilms HIV Stem cell injection

Volume 9, Number 2 Review Articles

Management of Men Diagnosed With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Who Have Failed Traditional Management

Management Update

Dean A Tripp Michel Pontari Andrew P Baranowski Richard Berger J Curtis Nickel

For many patients, the traditional biomedical model that physicians have used to manage chronic prostatitis does not work. This article describes innovative treatment strategies for chronic prostatitis/chronic pelvic pain syndrome, with an emphasis on novel biomedical physical therapy and biopsychosocial approaches to the management of individualized patient symptoms. [Rev Urol. 2007;9(2):63-72]

Chronic pelvic pain syndrome Chronic prostatitis Physiotherapy

Volume 9, Number 2 Meeting Reviews

Urinary Tract Infections and Resistant Bacteria

Meeting Review

J Curtis Nickel

Highlights of a Symposium at the Combined Meeting of the 25th International Congress of Chemotherapy (ICC) and the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), March 31-April 3, 2007, Munich, Germany [Rev Urol. 2007;9(2):78-80]

Community-acquired urinary tract infection Pathogenesis Antimicrobial therapy

Volume 9, Number 2 Literature Reviews

Reviewing the Literature

J Curtis Nickel

Volume 10, Number 3 Review Articles

Nutraceuticals in Prostate Disease: The Urologist’s Role

Treatment Update

Claus G Roehrborn Daniel Shoskes Mark A Moyad J Curtis Nickel

Interest in and use of complementary and alternative therapies, especially nutraceuticals, is high in prostate disease. These therapies have shown potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer. Some have produced results equal to or better than pharmaceuticals currently prescribed for BPH. In category III prostatitis, some nutraceuticals may offer relief to patients who get little from standard therapy. Because it is becoming apparent that inflammation may play a role in the progression of BPH and development of prostate cancer, nutraceuticals, which commonly have anti-inflammatory properties, may play a role. These therapies have also shown potential in prostate cancer treatment and prevention, especially those that also reduce cardiovascular events or risk. Nevertheless, uses of some nutraceuticals in prostate disease have had less desirable consequences, showing lack of efficacy, adulteration, and/or severe side effects or drug interactions. By ensuring that these therapies undergo careful study for effectiveness, quality, and safety, urologists can look forward to adding them to their evidence-based armamentarium for prostate disease. [Rev Urol. 2008;10(3):192-206]

Prostate cancer Benign prostatic hyperplasia Prostatitis Complementary or alternative medical therapy Nutraceuticals

Volume 10, Number 2 Meeting Reviews

The Multidisciplinary Approach to Defining the Urologic Chronic Pelvic Pain Syndromes

Meeting Review

J Curtis Nickel

Report from a National Institutes of Health Workshop, December 13-14, 2007, Baltimore, MD [Rev Urol. 2008;10(2):157-159]

Interstitial cystitis Chronic pelvic pain syndrome Chronic prostatitis Painful bladder syndrome Irritable bowel syndrome Fibromyalgia Chronic fatigue syndrome

Volume 10, Number 2 Meeting Reviews

Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Finding a Way Forward in the United Kingdom

Meeting Review

Marina Cameron Meesha Patel J Curtis Nickel

Report from the First United Kingdom Symposium on Chronic Prostatitis, January 30, 2008, London, United Kingdom [Rev Urol. 2008;10(2):160-163]

Prostate Chronic pelvic pain syndrome Prostatitis Pain Psychosocial aspects of pain Alternative treatments